ChemoTech – innovator in gentle cancer treatment and effective pain management
ChemoTech is a Scandinavian company based in Malmö, Sweden. The company’s founders have extensive experience of cancer treatment through surgical oncology and clinical development. The company is dedicated to using its unique patented know-how to develop innovation in cancer care through genuine research and clinical trials.
Launching the IQWave™. Following extensive research and development, ChemoTech recently launched the IQWave™ – the next generation of electrochemotherapy devices with gentle yet effective and flexible treatment capabilities. The IQWave™ has been developed to achieve positive clinical outcomes on a level previously not possible. The IQWave™ is approved for the treatment of a wide range of tumours. Read more»
Next steps. The next step for ChemoTech is to expand its product portfolio into effective pain management for cancer patients, and a minimally invasive treatment method for prostate cancer.
Established distribution. ChemoTech has established distribution channels and a network of key opinion leaders in Europe, the Middle East, Asia and Africa.